Data from cDNA microarray and cytokine array analyses confirmed that EBNA2 increases CCL3 and CCL4 expression in DLBCL cells, in turn leading to increased survival signaling, including via the Btk and NF-κB pathways. This evidence concerns the gene CCL4 and diffuse large B-cell lymphoma.